Funding for this research was provided by:
National Natural Science Foundation of China (81772228)
Mega-projects of Science Research for the thirteenth Five-Year Plan (2018ZX10101001)
CAMS Innovation Fund for Medical Sciences (2016-I2M-1-014 and 2017-I2M-B&R-12)
Received: 16 September 2020
Accepted: 6 December 2020
First Online: 21 January 2021
Ethics approval and consent to participate
: Animals were treated according to the guidelines of the Regulations for the Administration of Laboratory Animals (Decree No. 2 of the State Science and Technology Commission of the People’s Republic of China, 1988), the American Society of Mammologists, and the European Union legislation ((Directive 86/609/EEC). Sampling procedures were approved by the Ethics Committee of the Institute of Pathogen Biology, Chinese Academy of Medical Sciences & Peking Union Medical College (Approval number: IPB EC20100415). Each trapping campaign was approved by national, regional, and local health authorities. Approval notices for trapping and investigation of rodents were provided by the Ministry of Health Council of Medical Sciences, National Ethics Committee for Health Research (NHCHR) Lao PDR, number 51/NECHR, and by the Ethical Committee of Mahidol University, Bangkok, Thailand, number 0517.1116/661 [CitationRef removed]. None of the species are considered to be endangered and none are included on the CITES list or the Red List (IUCN).
: Not applicable.
: The authors declare that they have no competing interests